Glibenclamide + Metformin + Rosiglitazone

Glibenclamide+Metformin+Rosiglitazone is used in the treatment of type 2 diabetes mellitus.

Glibenclamide + Metformin + Rosiglitazone is a combination of three antidiabetic medicines: Glibenclamide , Metformin and Rosiglitazone. They work by different mechanisms to provide better control of blood sugar when single or dual therapy is not effective. Glibenclamide is a sulfonylurea which works by increasing the amount of insulin released by the pancreas in order to lower the blood glucose. Metformin is a biguanide. It works by lowering glucose production in the liver, delaying glucose absorption from intestines and increasing the body's sensitivity to insulin. Rosiglitazone is a thiazolidinedione which further increases insulin sensitivity. Glibenclamide, Metformin and Rosiglitazone. They work by different mechanisms to provide better control of blood sugar when single or dual therapy is not effective. Glibenclamide is a sulfonylurea which works by increasing the amount of insulin released by the pancreas in order to lower the blood glucose. Metformin is a biguanide. It works by lowering glucose production in the liver, delaying glucose absorption from intestines and increasing the body's sensitivity to insulin. Rosiglitazone is a thiazolidinedione which further increases insulin sensitivity.

Hypoglycemia (low blood glucose level), Nausea1a, Taste change, Diarrhea, Stomach pain, Headache, Edema (swelling), Weight gain, Blurred vision, Bone fracture, Respiratory tract infection